We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

IDS rs113993952: Understanding Hunter Syndrome Carrier Status

rs113993952
Carrier Status
Moderate evidenceGene: IDS

The genetic variant rs113993952 is located within the IDS gene, which provides instructions for an enzyme essential for breaking down complex sugars in the body. This specific variant is recognized in clinical databases as being associated with carrier status for Mucopolysaccharidosis type II, also known as Hunter syndrome.

What each genotype means

A/ALower attention

Typical IDS gene sequence

This genotype represents the common, non-variant sequence at this position in the IDS gene. It is not associated with Hunter syndrome.

This is the most common genotype observed in the general population.

A/TModerate attention

Hunter syndrome carrier status

This genotype indicates the presence of a variant in the IDS gene associated with Mucopolysaccharidosis type II (Hunter syndrome). Because this condition is X-linked, individuals with this genotype are considered carriers and are typically unaffected unless another mutation is present in the IDS gene.

This specific genotype is rare in the general population.

What is the rs113993952 Variant?

The variant rs113993952 is a specific change in the DNA sequence located on the X chromosome at position 149,503,494. In the context of human genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. Because this variant is found within the IDS gene, it is categorized by its potential to alter the function of the protein that the gene encodes. Geneticists track these variants to understand how they contribute to inherited conditions. While many variants in the human genome are benign and have no impact on health, others are studied closely because they are linked to specific clinical phenotypes. The rs113993952 variant is specifically noted in genetic catalogs for its association with the carrier state of an X-linked recessive condition, meaning it is a point of interest for individuals exploring their family health history or reproductive genetic screening.

The Role of the IDS Gene

The IDS gene is responsible for producing an enzyme called iduronate-2-sulfatase (I2S). This enzyme plays a critical role in the body's lysosomal system, which acts as a recycling center for cells. Specifically, I2S is required to break down large sugar molecules known as glycosaminoglycans (GAGs), or mucopolysaccharides. When the IDS gene functions normally, these sugar molecules are broken down and removed from the body efficiently. However, if the gene contains a pathogenic variant that significantly reduces or eliminates the activity of the I2S enzyme, GAGs can accumulate in various tissues and organs. This accumulation is the underlying cause of Mucopolysaccharidosis type II, or Hunter syndrome. Because the IDS gene is located on the X chromosome, the inheritance pattern is X-linked, which explains why the condition primarily affects males, who have only one X chromosome and therefore lack a backup copy of the gene.

Research and Clinical Evidence

Research into the IDS gene has identified hundreds of variants that can lead to Hunter syndrome. The evidence linking specific variants like rs113993952 to carrier status is derived from clinical observations and genetic testing databases. In the context of X-linked recessive inheritance, a female who carries one altered copy of the IDS gene is typically considered a carrier. Because females have two X chromosomes, the presence of a functional copy of the gene on the other X chromosome usually compensates for the variant, meaning the carrier does not typically exhibit the severe symptoms of the disorder. However, clinical literature notes that symptomatic carrier females have been reported in rare instances. The evidence strength for this variant is categorized as moderate, reflecting its documented presence in clinical databases as a marker for carrier status. It is important to note that the presence of this variant does not constitute a diagnosis of Hunter syndrome itself.

Population Frequency and Distribution

The rs113993952 variant is considered rare in the general population. Hunter syndrome itself is a rare condition, with an estimated incidence ranging from 1 in 100,000 to 1 in 150,000 male births. Because the variant is rare, it is not commonly found in the general population, and its frequency can vary significantly depending on the ancestral background of the population being studied. Genetic databases like gnomAD provide data on the frequency of such variants, but for rare, disease-associated alleles, the numbers are often very low. This rarity means that most individuals will not carry this specific variant. When it is identified, it is usually through targeted genetic testing or carrier screening programs rather than routine population-wide genomic sequencing. Understanding the rarity of this variant is essential for interpreting its clinical significance in a personal genetic report.

Interpreting Your Genetic Information

If you have received information regarding the rs113993952 variant, it is important to approach the data with context. This information is intended for educational purposes and should not be used to diagnose any medical condition. If you are concerned about your carrier status or family history, the most appropriate step is to consult with a certified genetic counselor or a medical professional. They can help interpret the results in the context of your personal and family health history, explain the implications of X-linked inheritance, and discuss whether further diagnostic testing is necessary. You cannot change your genetic code, but you can use this information to make informed decisions about your health and family planning. Always rely on clinical-grade testing and professional medical guidance rather than direct-to-consumer reports when making significant healthcare decisions.

How common is this variant?

The rs113993952 variant is rare in the general population, with its frequency being very low across most ancestral groups.

Frequently asked questions

What is Hunter syndrome?

Hunter syndrome, or Mucopolysaccharidosis type II, is a rare, inherited, X-linked recessive disorder caused by a deficiency of the enzyme iduronate-2-sulfatase. This deficiency leads to the accumulation of complex sugars in body tissues, which can cause a range of multisystem health issues.

What does it mean to be a carrier of an X-linked condition?

Being a carrier of an X-linked recessive condition typically means you have one altered copy of a gene on one of your X chromosomes. Because females have two X chromosomes, the other, normal copy of the gene usually compensates for the variant, preventing the development of the full disorder.

Can females develop Hunter syndrome?

While Hunter syndrome is an X-linked recessive disorder that primarily affects males, it is theoretically possible for a female to be affected if both of her X chromosomes carry a pathogenic variant. Symptomatic carrier females have also been documented in rare cases.

Should I be worried if I have this variant?

The presence of this variant indicates carrier status, not a diagnosis of the disease. If you are concerned about your results, you should discuss them with a genetic counselor who can provide context based on your specific health history and family background.

Sources & further reading

Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs113993952?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in IDS